Latest Listings And Ipos News

Genetic Technologies Limited reports a 36% increase in half-year losses amid voluntary administration, followed by a recapitalisation and sale of core assets. The company pivots towards new financial services acquisitions under fresh leadership.

Invion Limited has disclosed that the US FDA granted Orphan Drug Designation for its lead cancer drug candidate INV043, explaining recent unusual trading activity in its shares. The company confirmed it was unaware of the FDA decision prior to its public release and has now complied with continuous disclosure rules.

Vital Metals Limited has voluntarily suspended trading of its shares pending a key announcement on a capital raise, following an ASX price and volume query.

Whitefield Income Limited has reported a $7.8 million net profit in its first seven months as an ASX-listed company, alongside steady monthly dividends annualised at 8%. The company’s portfolio outperformed its benchmark, signaling a promising start post-IPO.

Ovanti Limited has secured a strategic three-year partnership with Shift4 Payments to launch its innovative Buy Now Pay Later services across over 100,000 US merchants, leveraging AI-driven credit models and stablecoin-backed funding.

Xamble Group Limited is accelerating its transformation into Southeast Asia’s premier influencer marketing platform, reporting strong H1 revenue growth and launching a strategic rights issue to fund expansion and technology upgrades.

Lycopodium Limited delivered FY25 results at the top end of guidance, reporting strong revenue and profit growth alongside strategic moves to deepen its global footprint, notably through the acquisition of Argentinian engineering firm SAXUM.

Wingara AG Limited has officially terminated its planned placement and loan agreement with Terra Firma Equity Limited, leaving its capital raising strategy uncertain.

StepChange Holdings has reported FY25 results that beat expectations, following its acquisition of StepChange Consultants and successful ASX listing. The company sets a promising stage for FY26 with strong operational momentum.

StepChange Holdings Limited reported a $2.69 million loss for its inaugural financial period ending June 2025, completed a significant $18.3 million acquisition, and successfully listed on the ASX in July 2025.

Step One Clothing reported modest FY25 revenue growth amid a challenging retail environment, driven by strong UK performance and a strategic shift to balance discounting and profitability.

Step One Clothing Limited reported a 2.8% revenue increase to $86.9 million and a 2.0% rise in net profit after tax to $12.65 million for FY25, while EBITDA declined 3.9% due to increased promotional activity. The company reinforced its sustainability credentials with FSC® certification and detailed emissions reporting.